What is it about?
Apparently Janus-faced ambiguous interaction between obesity and breast cancer risk depending on the menopausal status of women is based on misunderstandings. In young women, obesity associated insulin resistance is usually moderate and may be counteracted by their defensive serum estrogen level. It is not obesity but rather the sufficient estrogen level, which reduces the breast cancer risk in obese young females. By contrast, obesity in hormonally challenged older women is higher risk.
Featured Image
Photo by AllGo - An App For Plus Size People on Unsplash
Why is it important?
Among young women, not only obesity but rather the hormonal and metabolic imbalances mean high risk for breast cancer, which occurs even in lean patients. Young women with PCOS or BRCA gene mutations may exhibit high risk for breast cancer, although they are not obese.
Perspectives
Exogenous estrogen treatment may prevent the development of breast cancer in both premenopausal and postmenopausal obese women.
professor Zsuzsanna Suba
National Institute of Oncology Budapest
Read the Original
This page is a summary of: Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women, Recent Patents on Anti-Cancer Drug Discovery, May 2013, Bentham Science Publishers,
DOI: 10.2174/157489213805290628.
You can read the full text:
Contributors
The following have contributed to this page
